dc.creator | Sharma H.S. | |
dc.creator | Muresanu D.F. | |
dc.creator | Lafuente J.V. | |
dc.creator | Sjöquist P.-O. | |
dc.creator | Patnaik R. | |
dc.creator | Sharma A. | |
dc.date.accessioned | 2020-09-02T22:28:14Z | |
dc.date.accessioned | 2022-11-08T20:21:18Z | |
dc.date.available | 2020-09-02T22:28:14Z | |
dc.date.available | 2022-11-08T20:21:18Z | |
dc.date.created | 2020-09-02T22:28:14Z | |
dc.date.issued | 2015 | |
dc.identifier | 52, 2, 882-898 | |
dc.identifier | 08937648 | |
dc.identifier | https://hdl.handle.net/20.500.12728/6250 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143952 | |
dc.language | en | |
dc.publisher | Humana Press Inc. | |
dc.subject | Blood-spinal cord barrier | |
dc.subject | Carfilzomib | |
dc.subject | H-290/51 | |
dc.subject | Heat shock protein | |
dc.subject | Nanoparticle | |
dc.subject | Spinal cord injury | |
dc.subject | Ubiquitin | |
dc.subject | antioxidant | |
dc.subject | carfilzomib | |
dc.subject | copper nanoparticle | |
dc.subject | h 290 51 | |
dc.subject | heat shock protein | |
dc.subject | heat shock protein 72 | |
dc.subject | nanoparticle | |
dc.subject | silica nanoparticle | |
dc.subject | silver nanoparticle | |
dc.subject | ubiquitin | |
dc.subject | unclassified drug | |
dc.subject | antioxidant | |
dc.subject | carfilzomib | |
dc.subject | copper | |
dc.subject | H290-51 | |
dc.subject | heat shock protein 72 | |
dc.subject | indole derivative | |
dc.subject | nanoparticle | |
dc.subject | nerve protein | |
dc.subject | neuroprotective agent | |
dc.subject | oligopeptide | |
dc.subject | proteasome inhibitor | |
dc.subject | silicon dioxide | |
dc.subject | silver | |
dc.subject | ubiquitin | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | blood spinal cord barrier | |
dc.subject | controlled study | |
dc.subject | drug effect | |
dc.subject | edema | |
dc.subject | male | |
dc.subject | nerve cell lesion | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | permeability barrier | |
dc.subject | protein expression | |
dc.subject | rat | |
dc.subject | spinal cord dorsal horn | |
dc.subject | spinal cord injury | |
dc.subject | thoracic spinal cord | |
dc.subject | animal | |
dc.subject | biosynthesis | |
dc.subject | complication | |
dc.subject | edema | |
dc.subject | genetics | |
dc.subject | metabolism | |
dc.subject | pathology | |
dc.subject | preclinical study | |
dc.subject | spinal cord | |
dc.subject | Spinal Cord Injuries | |
dc.subject | thoracic vertebra | |
dc.subject | upregulation | |
dc.subject | Wistar rat | |
dc.subject | Animals | |
dc.subject | Antioxidants | |
dc.subject | Copper | |
dc.subject | Drug Evaluation, Preclinical | |
dc.subject | Edema | |
dc.subject | HSP72 Heat-Shock Proteins | |
dc.subject | Indoles | |
dc.subject | Male | |
dc.subject | Nanoparticles | |
dc.subject | Nerve Tissue Proteins | |
dc.subject | Neuroprotective Agents | |
dc.subject | Oligopeptides | |
dc.subject | Proteasome Inhibitors | |
dc.subject | Rats | |
dc.subject | Rats, Wistar | |
dc.subject | Silicon Dioxide | |
dc.subject | Silver | |
dc.subject | Spinal Cord | |
dc.subject | Spinal Cord Injuries | |
dc.subject | Thoracic Vertebrae | |
dc.subject | Ubiquitin | |
dc.subject | Up-Regulation | |
dc.title | Nanoparticles Exacerbate Both Ubiquitin and Heat Shock Protein Expressions in Spinal Cord Injury: Neuroprotective Effects of the Proteasome Inhibitor Carfilzomib and the Antioxidant Compound H-290/51 | |
dc.type | Article | |